WeightNameValue
1000 Titel
  • Synergistic Activity of the Tyrocidines, Antimicrobial Cyclodecapeptides from Bacillus aneurinolyticus, with Amphotericin B and Caspofungin against Candida albicans Biofilms
1000 Autor/in
  1. Troskie, Anscha Mari |
  2. Rautenbach, Marina |
  3. Delattin, Nicolas |
  4. Vosloo, Johan Arnold |
  5. Dathe, Margitta |
  6. Cammue, Bruno P. A. |
  7. Thevissen, Karin |
1000 Erscheinungsjahr 2014
1000 LeibnizOpen
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2014-04-21
1000 Erschienen in
1000 Quellenangabe
  • 58(7): 3697-3707
1000 FRL-Sammlung
1000 Verlagsversion
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068576/ |
  • http://dx.doi.org/10.1128/AAC.02381-14 |
1000 Ergänzendes Material
  • http://aac.asm.org/content/58/7/3697/suppl/DCSupplemental |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Tyrocidines are cationic cyclodecapeptides from Bacillus aneurinolyticus that are characterized by potent antibacterial and antimalarial activities. In this study, we show that various tyrocidines have significant activity against planktonic Candida albicans in the low-micromolar range. These tyrocidines also prevented C. albicans biofilm formation in vitro. Studies with the membrane-impermeable dye propidium iodide showed that the tyrocidines disrupt the membrane integrity of mature C. albicans biofilm cells. This membrane activity correlated with the permeabilization and rapid lysis of model fungal membranes containing phosphatidylcholine and ergosterol (70:30 ratio) induced by the tyrocidines. The tyrocidines exhibited pronounced synergistic biofilm-eradicating activity in combination with two key antifungal drugs, amphotericin B and caspofungin. Using a Caenorhabditis elegans infection model, we found that tyrocidine A potentiated the activity of caspofungin. Therefore, tyrocidines are promising candidates for further research as antifungal drugs and as agents for combinatorial treatment.
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/creator/VHJvc2tpZSwgQW5zY2hhIE1hcmk=|https://frl.publisso.de/adhoc/creator/UmF1dGVuYmFjaCwgTWFyaW5h|https://frl.publisso.de/adhoc/creator/RGVsYXR0aW4sIE5pY29sYXM=|https://frl.publisso.de/adhoc/creator/Vm9zbG9vLCBKb2hhbiBBcm5vbGQ=|https://frl.publisso.de/adhoc/creator/RGF0aGUsIE1hcmdpdHRh|https://frl.publisso.de/adhoc/creator/Q2FtbXVlLCBCcnVubyBQLiBBLg==|https://frl.publisso.de/adhoc/creator/VGhldmlzc2VuLCBLYXJpbg==
1000 Label
1000 Förderer
  1. European Union |
  2. National Research Foundation (South Africa) |
  3. - |
  4. KU Leuven |
  5. IWT-Vlaanderen |
1000 Fördernummer
  1. -
  2. -
  3. -
  4. -
  5. -
1000 Förderprogramm
  1. Erasmus Mundus Action 2 Programme
  2. -
  3. BIOPEP Peptide Fund
  4. Industrial Research Fund
  5. Industrial Research Fund
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer European Union |
    1000 Förderprogramm Erasmus Mundus Action 2 Programme
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer National Research Foundation (South Africa) |
    1000 Förderprogramm -
    1000 Fördernummer -
  3. 1000 joinedFunding-child
    1000 Förderer - |
    1000 Förderprogramm BIOPEP Peptide Fund
    1000 Fördernummer -
  4. 1000 joinedFunding-child
    1000 Förderer KU Leuven |
    1000 Förderprogramm Industrial Research Fund
    1000 Fördernummer -
  5. 1000 joinedFunding-child
    1000 Förderer IWT-Vlaanderen |
    1000 Förderprogramm Industrial Research Fund
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6405577.rdf
1000 Erstellt am 2017-11-30T09:11:52.292+0100
1000 Erstellt von 25
1000 beschreibt frl:6405577
1000 Bearbeitet von 288
1000 Zuletzt bearbeitet Thu Aug 18 07:48:10 CEST 2022
1000 Objekt bearb. Tue Mar 09 11:50:10 CET 2021
1000 Vgl. frl:6405577
1000 Oai Id
  1. oai:frl.publisso.de:frl:6405577 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source